company background image
CMP logo

Compumedics CHIA:CMP Stock Report

Last Price

AU$0.28

Market Cap

AU$57.6m

7D

-6.8%

1Y

22.2%

Updated

24 May, 2025

Data

Company Financials +

Compumedics Limited

CHIA:CMP Stock Report

Market Cap: AU$57.6m

CMP Stock Overview

Engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe. More details

CMP fundamental analysis
Snowflake Score
Valuation5/6
Future Growth5/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Rewards

Trading at 66.8% below our estimate of its fair value

Earnings are forecast to grow 44.53% per year

Trading at good value compared to peers and industry

Risk Analysis

Does not have a meaningful market cap (A$58M)


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Compumedics Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Compumedics
Historical stock prices
Current Share PriceAU$0.28
52 Week HighAU$0.35
52 Week LowAU$0.23
Beta0.48
1 Month Change-3.51%
3 Month Change-6.78%
1 Year Change22.22%
3 Year Change41.03%
5 Year Change-45.00%
Change since IPO150.00%

Recent News & Updates

Recent updates

Shareholder Returns

CMPAU Medical EquipmentAU Market
7D-6.8%-1.3%0.1%
1Y22.2%-11.0%6.2%

Return vs Industry: CMP exceeded the Australian Medical Equipment industry which returned -11% over the past year.

Return vs Market: CMP exceeded the Australian Market which returned 6.2% over the past year.

Price Volatility

Is CMP's price volatile compared to industry and market?
CMP volatility
CMP Average Weekly Movement12.5%
Medical Equipment Industry Average Movement12.1%
Market Average Movement9.5%
10% most volatile stocks in AU Market17.1%
10% least volatile stocks in AU Market4.0%

Stable Share Price: CMP has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: CMP's weekly volatility (12%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987155David Burtonwww.compumedics.com.au

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients’ physiological data; Somté PSG; Okti; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; Somté, an investigative tool; Siesta 802; and Somté PSG. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG amplifiers; Grael 4K-EEG amplifiers; Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Okti, an portable EEG amplifier; and Siesta 802, a multi-functional ambulatory recording device.

Compumedics Limited Fundamentals Summary

How do Compumedics's earnings and revenue compare to its market cap?
CMP fundamental statistics
Market capAU$57.61m
Earnings (TTM)-AU$1.59m
Revenue (TTM)AU$47.37m
1.2x
P/S Ratio
-36.2x
P/E Ratio

Is CMP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CMP income statement (TTM)
RevenueAU$47.37m
Cost of RevenueAU$22.45m
Gross ProfitAU$24.92m
Other ExpensesAU$26.52m
Earnings-AU$1.59m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.0083
Gross Margin52.61%
Net Profit Margin-3.36%
Debt/Equity Ratio53.4%

How did CMP perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/24 18:51
End of Day Share Price 2025/05/23 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Compumedics Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ian MartinNew Street Research LLP
Paul JenszPAC Partners Securities Pty. Ltd.
Stephen ScottTaylor Collison Limited